34927-63-4

Basic information

• Product Name: 1,1'-(9H-fluorene-2,7-diyl)bis(4-piperidinobutan-1-one)
• Synonyms: 1,1'-(9H-fluorene-2,7-diyl)bis(4-piperidinobutan-1-one);RMI 10233;1,1'-(9H-Fluorene-2,7-diyl)bis(4-piperidino-1-butanone)
• CAS NO: 34927-63-4
• Molecular Formula: C₃₁H₄₀N₂O₂
• Molecular Weight: 472.6615
• EINECS: 252-294-7
• Mol File: 34927-63-4.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 659.6°Cat760mmHg
• Flash Point: 273.7°C
• Appearance: /
• Density: 1.113g/cm³
• CAS DataBase Reference: 1,1'-(9H-fluorene-2,7-diyl)bis(4-piperidinobutan-1-one)(CAS DataBase Reference)
• NIST Chemistry Reference: 1,1'-(9H-fluorene-2,7-diyl)bis(4-piperidinobutan-1-one)(34927-63-4)
• EPA Substance Registry System: 1,1'-(9H-fluorene-2,7-diyl)bis(4-piperidinobutan-1-one)(34927-63-4)

Safety Data

• Hazardous Substances Data: 34927-63-4(Hazardous Substances Data)

Usage

Molecular Structure

Complex, composed of two piperidinobutan-1-one molecules linked by a fluorene-2,7-diyl bridge

Industry Usage

Pharmaceutical industry and research laboratories

Therapeutic Properties

Potential analgesic and anesthetic effects

Piperidinobutan-1-one moiety

Associated with analgesic and anesthetic effects

Fluorene bridge

Provides stability and structure to the molecule

Research Interest

Further studies on potential medical applications and as a building block for the synthesis of other novel compounds

Upstream product

• 110-89-4 piperidine 
• 86-73-7 9H-fluorene 
• 34927-52-1 2,7-Bis(4-chlorobutyryl)fluorene 
• 4635-59-0 4-Chlorobutanoyl chloride 

Downstream Products

• 34927-52-1 2,7-Bis(4-chlorobutyryl)fluorene 

Relevant articles and documents

Bis-basic ketones of fluorene and fluorenone

The novel bis-basic ketones of fluorene and fluorenone of the present invention have antiviral activity when administered orally and parenterally. These compounds are represented by the following formula: STR1 wherein Z is oxygen or H2 ; each A is a straight or branched alkylene chain having from 1 to about 6 carbon atoms; and each Y is A. the group STR2 wherein R1 and R2 are individually hydrogen, (lower)alkyl having from 1 to about 6 carbon atoms, cycloalkyl having from 3 to 6 carbon atoms, alkenyl of from 3 to 6 carbon atoms and having the vinyl unsaturation in other than the 1-position of the alkenyl group; or B. the group STR3 WHEREIN N IS A WHOLE INTEGER FROM 4 TO 6, AND R3 is hydrogen, (lower)alkyl of 1 to about 4 carbon atoms, phenyl, or benzyl and can be linked to any one of the carbon atoms of the heterocyclic group; or C. the group STR4 wherein X is oxygen or NR4, and R4 is hydrogen or (lower)alkyl of from 1 to about 4 carbon atoms; or D. the group STR5 WHEREIN P IS A WHOLE INTEGER FROM 2 TO 3, AND M IS A WHOLE INTEGER FROM 1 TO 2; OR A PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT OF SAID BASE. These new compounds may be prepared by several different methods which are described.